OTC · Medical - Diagnostics & Research

Many Bright Ideas Technologies Inc. (MBGNF) Stock

$0.01 +0.00% OTC: MBGNF Healthcare

Many Bright Ideas Technologies Inc. (MBGNF) currently operates with minimal business activity.

Valuation

MetricValue
Price$0.01
Market Cap$101821
P/E Ratio-2.19
P/B Ratio-0.44
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.01
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE21.27%
ROA-464.69%
ROCE20.23%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.83
Current Ratio0.04

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Latest News

Canadian Investment Regulatory Organization Trading Halt - MBI.H CNW Group · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.24
EV / EBITDA-6.39
FCF Yield-49.94%
Quick Ratio0.04
Interest Coverage—
Return 1Y-41.00%
Return 3Y-94.42%
Return 5Y—

Ownership

Insiders Held49.22%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACMSYAccuStem Sciences Limited $0.13 -7.14% -1.08 $0 0.00%
CHOOFChoom Holdings Inc. $0.00 — 0.00 $4670 0.00%
CRVWCareView Communications, Inc. $0.04 -13.23% -7.69 $23.36M 0.00%
EVRRFMolecule Holdings Inc. $0.00 — -0.11 $626130 0.00%
GTHPGuided Therapeutics, Inc. $0.24 -7.92% -5.47 $23.56M 0.00%

About Many Bright Ideas Technologies Inc.

Many Bright Ideas Technologies Inc. (MBGNF) currently operates with minimal business activity. This Vancouver-based company, founded in 2006, adopted its current name in June 2022, having previously been known as Med BioGene Inc. Historically, its focus was within the life sciences sector, specifically dedicated to developing and bringing to market genomic diagnostic solutions for non-small-cell lung cancer. Although its operations are currently limited, the company's stated strategic objective is to commercialize various technologies across a range of industrial sectors.

Many Bright Ideas Technologies Inc. is headquartered in CA.

Many Bright Ideas Technologies Inc. (MBGNF) stock trades at $0.01 with a market capitalization of $101821. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.19, reflecting a net loss over the last twelve months, a negative price-to-book of -0.44, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.01, and currently trades at or near its 52-week high.

On profitability, Many Bright Ideas Technologies Inc. generates a return on equity (ROE) of 21.27% (not meaningful, as shareholders' equity is negative), return on capital employed of 20.23%.

Official website: www.medbiogene.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1166.51 -1.36% JNJ Johnson & Johnson $248.61 -5.73% ABBV AbbVie Inc. $274.31 -2.42% MRK Merck & Company, Inc. Common Stock (new) $141.98 -2.39% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.76 -0.20% NVS Novartis AG $142.41 -0.99% TMO Thermo Fisher Scientific Inc $663.04 +0.12% AZN AstraZeneca PLC $155.82 -1.59% AMGN Amgen Inc. $412.84 -1.13% GILD Gilead Sciences, Inc. $147.92 -1.67% ABT Abbott Laboratories $102.67 +0.83% NVO Novo Nordisk A/S $38.06 -1.35%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.